Clinical Trials Browser

INDUSTRY × Lymphoma × devimistat × Clear all

NCT00741403 2016-12-29

A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies

Phase 1 Completed

Lymphoma, Neoplasm Metastasis, Neoplasms, Recurrence